Dr. Robert Andtbacka Discusses T-VEC Plus Ipilimumab in Unresected Melanoma

onclivetv has 407 videos Subscribe Here

Description: Robert H. I. Andtbacka, MD, CM, a surgeon and investigator with Intermountain Healthcare and Huntsman Cancer Institute, discusses the safety and efficacy of talimogene laherparepvec (T-VEC) in combination with ipilimumab in patients with previously untreated, unresected stage IIIB-IV melanoma.

To view more on melanoma, visit
Shared By : onclivetv
Posted on : 09/10/14
Added : 5 years ago